Application of gene therapy in the treatment of superficial digital flexor tendon injury in horses.

Application of gene therapy in the treatment of superficial digital flexor tendon injury in horses.
复制标题

DOI:
10.4314/ovj.v10i3.3
复制
发表时间:
2020-10
影响因子:
1.2
通讯作者:
Zakirova E
Zakirova E
中科院分区:
其他
文献类型:
--
作者:
Aimaletdinov A;Mindubaeva G;Khalikova S;Kabwe E;Salmakova A;Alexandrova N;Rutland C;Rizvanov A;Zakirova E

文献摘要

参考文献

被引文献

相似文献

肌腱损伤是马骨科疾病的最常见原因之一。此类伤害需要长期的治疗和康复过程。治疗这些损伤最有希望的方法是使用重组蛋白和基因疗法。在这项工作中,我们评估了含有两种物种特异性编码序列,即血管内皮生长因子 164 (VEGF164) 和成纤维细胞生长因子 2 (FGF2) 的质粒 DNA (pDNA) 在治疗指浅屈肌腱严重损伤中的治疗效果。 pDNA 构建体被用来修复马受损的浅表屈肌腱。这项研究表明,在损伤部位注射编码 VEGF164 和 FGF2 基因的 pDNA 可以增强受损肌腱的再生活性。这项研究展示了基因构建体 (pDNA) 的治疗特性,并有助于推动这些疗法的使用。
Tendon injuries are one of the most common causes of orthopedic disorders in horses. Such injuries involve a long course of treatment and recovery. The most promising method of treating these injuries is the use of recombinant proteins and gene therapy. In this work, we evaluated the therapeutic efficacy of plasmid DNA (pDNA) containing two species-specific coding sequences, i.e. vascular endothelial growth factor 164 (VEGF164) and fibroblast growth factor 2 (FGF2), in the treatment of severe damage to the tendon of the superficial digital flexor. A pDNA construct was used to restore the damaged superficial digital flexor tendon in the horse. This study showed that the administration of pDNA encoding VEGF164 and FGF2 genes at the injury area increased the regenerative activities of the damaged tendon. This study shows the therapeutic properties of genetic constructs (pDNA) and contributes to the advancements in the use of these therapies.
DOI: 10.1111/j.2042-3306.2009.00021.x
发表时间: 2010-05-01
影响因子: 2.2
作者:
O'Meara, B.;Bladon, B.;Lischer, C. J.
通讯作者: Lischer, C. J.
DOI: 10.1358/dot.2002.38.12.820100
发表时间: 2002-12-01
期刊: DRUGS OF TODAY
影响因子: 1.8
作者:
Sylvén, C
通讯作者: Sylvén, C
DOI: 10.1007/s40256-016-0210-3
发表时间: 2017-06
期刊: American journal of cardiovascular drugs : drugs, devices, and other interventions
影响因子: --
作者:
Deev R;Plaksa I;Bozo I;Isaev A
通讯作者: Isaev A
基本 FGF 或 VEGF 基因治疗可纠正肌腱内在愈合能力的不足
DOI: 10.1038/srep20643
发表时间: 2016-02-11
期刊: Scientific reports
影响因子: 4.6
作者:
Tang JB;Wu YF;Cao Y;Chen CH;Zhou YL;Avanessian B;Shimada M;Wang XT;Liu PY
通讯作者: Liu PY
DOI: 10.1111/vru.12628
发表时间: 2018-09-01
影响因子: 1.7
作者:
O'Brien, Etienne J. O.;Smith, Roger K. W.
通讯作者: Smith, Roger K. W.